Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 2,977,780 | 2,905,481 | 2,721,043 | 2,450,928 | 2,586,276 |
| Cost of Goods | 566,590 | 507,920 | 507,690 | 500,340 | 523,250 |
| Gross Profit | 2,398,020 | 2,188,100 | 2,124,670 | 2,043,020 | 2,075,370 |
| Operating Expenses | 1,505,990 | 1,321,590 | 1,290,530 | 1,269,970 | 1,531,760 |
| Operating Income | 905,790 | 1,076,891 | 923,513 | 680,958 | 531,516 |
| Other Income | -41,800 | -271,411 | -135,553 | 122,002 | 72,144 |
| Pre-tax Income | 863,990 | 805,480 | 787,960 | 802,960 | 603,660 |
| Income Tax | 141,100 | 185,280 | 181,260 | 184,690 | 135,150 |
| Net Income Continuous | 728,747 | 668,387 | 627,144 | 595,794 | 459,954 |
| Net Income | $728,747 | $668,387 | $627,144 | $595,794 | $459,954 |
| EPS Basic Total Ops | 0.13 | 0.12 | 0.11 | 0.10 | 0.08 |
| EPS Basic Continuous Ops | 0.13 | 0.12 | 0.11 | 0.10 | 0.08 |
| EPS Diluted Total Ops | 0.13 | 0.12 | 0.11 | 0.10 | 0.08 |
| EPS Diluted Continuous Ops | 0.13 | 0.11 | 0.11 | 0.10 | 0.08 |
| EBITDA(a) | $1,037,200 | $1,184,251 | $1,016,543 | $789,018 | $1,009,316 |